Emvistegrast for colitis, ulcerative

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Mar 2024: Trial registered, NCT06290934
  2. 27 Mar 2024: Trial started, NCT06290934

The trials

NCT06290934: Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

State
Under way
Phase
Phase 2
People
228 planned
Started
27 Mar 2024
Primary completion
4 Mar 2026
Arms
Part A, Part B, Part C: Emvistegrast Dose A, Part A, Part B, Part C: Emvistegrast Dose B, Part A, Part B, Part C: Emvistegrast Dose C
Results
None posted
  1. 4 Mar 2024: Trial registered
  2. 27 Mar 2024: Trial started

How the status changed

  1. 16 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.